Trial Profile
Study of isavuconazole after posaconazole toxicity in leukemia patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 13 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018